Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset

Journal of Rheumatology

Volumn 26, Issue 12, 1999, Pages 2562-2571

  Wållberg Jonsson, Solveig ^a   Johansson, Henrik ^a   Öhman, Marie Louise ^b   Rantapää Dahlqvist, Solbritt ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cardiovascular disease; HLA B27; Inflammation; Mortality; Predictors; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIRHEUMATIC AGENT; CORTICOSTEROID; DIENESTROL; ESTRADIOL; ESTRIOL; HAPTOGLOBIN; HLA B27 ANTIGEN; HLA DR4 ANTIGEN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CERVICAL SPINE DISLOCATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PATIENT EDUCATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; STEROID THERAPY;

ADRENAL CORTEX HORMONES; AGE DISTRIBUTION; AGE OF ONSET; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; VENOUS THROMBOSIS;

EID: 0345072560     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553-6.
2. Isomäki HA, Mutru O, Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 1975;4:205-8.
3. Monson RR, Hall AP. Mortality among arthritics. J Chron Dis 1976;29:459-67.
4. Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982;11:81-6.
5. Pincus T. Callahan L, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
6. Symmons DPM, Prior P, Scott DL, Brown R, Hawkins CF. Factors influencing mortality in rheumatoid arthritis. J Chron Dis 1986;39:137-45.
7. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990;49:363-9.
8. Allebeck P, Ahlbom A, Alander E. Increased mortality among patients with rheumatoid arthritis, but where RA does not appear on the death certificate. Scand J Rheumatol 1981;10:301-6.
9. Prior P, Symmons DPM, Scott DL, Brown R. Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
10. Mutru O, Laakso M, Isomäki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ 1985;290:1811-3.
11. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
12. Jacobsson LTH, Knowler WC, Pillemer S, et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53.
13. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Cardiovascular mortality in females with rheumatoid arthritis. J Rheumatol 1995;22:1065-7.
14. Lebowitz WB. The heart in rheumatoid arthritis (rheumatoid disease). Ann Intern Med 1963;58:102-23.
15. Sokoloff L. Cardiac involvement in rheumatoid arthritis and allied disorders: current concepts. Mod Concepts Cardiovasc Dis 1964;33:847-50.
16. Cathcart ES, Spodick DH. Rheumatoid heart disease. A study of the incidence and nature of cardiac lesions in rheumatoid arthritis. J Med 1962;266:959-64.
17. Pincus T, Callahan BS. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis. Scand J Rheumatol 1989;Suppl 79:67-95.
18. Bercenovic E, Hurwics M-L. Rheumatoid arthritis and comorbidity. J Rheumatol 1990;17:888-92.
19. Wållberg-Jonsson S, Öhman M-L, Rantapää-Dahlqvist S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445-51.
20. WHO MONICA Project Principal Investigators. Prepared by Tuomilehto J, Kuulasma K, Torppa J. Geographic variation in mortality from cardiovascular disease - baseline data on the population demographics and cardiovascular mortality in the WHO MONICA Project. World Health Stat Q 1987;40:171-84.
21. Turner LW, Lansbury J. Low diastolic pressure as a clinical feature of rheumatoid arthritis and its possible etiologic significance. Am J Med Sci 1954;227:503-8.
22. Hazes JMW, Dijkmans BAC, Vandenbroucke JP, de Vries RRP, Cats A. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis 1990;49:980-2.
23. Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption and the risk of rheumatoid arthritis. Epidemiology 1994;5:525-32.
24. Hakala M, Ilonen J, Reijonen H, Knip M, Koivisto O, Isomäki H. No association between rheumatoid arthritis and insulin dependent diabetes mellitus: an epidemiologic and immunologic study. J Rheumatol 1992;19:856-8.
25. Rössner S, Löfmark C. Dyslipoproteinemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis 1977;28:41-52.
26. Svenson KLG, Lithell H, Hällgren R, Selinus I, Vessby B. Altered serum lipoproteins and enhanced lipoprotein elimination in patients with rheumatoid arthritis and other chronic inflammatory arthritides. Arch Intern Med 1987;147:1912-6.
27. Rantapää-Dahlqvist S, Wållberg-Jonsson S, Dahlén G. Lipoprotein(a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:366-8.
28. Skrifvars B, Laine V, Wegelius O. Sclerosis of the arteries of the extremities in rheumatoid arthritis. Acta Med Scand 1969;186:145-7.
29. Kalbak K. Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy. Ann Rheum Dis 1972;31:196-200.
30. Rasker JJ, Cosh JA. Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 1981;40:115-20.
31. Raynauld J-P, Wolfe F, Sibley JT, Fries JF. Mortality by cardiovascular disease and use of corticosteroids in rheumatoid arthritis [abstract]. Arthritis Rheum 1993;36:Suppl:S193.
32. Bacon PA, Kitas GD. The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis 1994;53:621-3.
33. Bely M, Apathy C, Beke-Martos E. Cardiac changes in rheumatoid arthritis. Acta Morphologica Hungarica 1992;40:149-86.
34. Wållberg-Jonsson S. On inflammation and cardiovascular disease in patients with rheumatoid arthritis [dissertation]. Umeå, Sweden: University of Umeå; 1996.
35. Ropes MW, Bennet GA, Cobb S. Diagnostic criteria for rheumatoid arthritis. Ann Rheum Dis 1959;18:49-53.
36. Nomenclature and criteria for diagnosis of ischemic heart disease; report of the Joint International Society and Federation of Cardiology/World Health Organisation Task Force on Standardization of Clinical Nomenclature. Circulation 1979;59:607-9.
37. Rose GA. Cardiovascular survey methods. 2nd ed. Geneva: World Health Organisation. Albany, New York. WHO Publishing Centre; 1992 Monograph Series.
38. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.
39. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 1972;135:185-206.
40. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
41. Lee ET. Statistical methods for survival data analysis. New York: John Wiley & Sons; 1992.
42. Norusis I. SPSS for Windows, Advanced Statistics Release 6.1. Chicago: Marketing Department SPSS Inc.: 1995.
43. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
44. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 1986;80:925-9.
45. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994;70:863-70.
46. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-63.
47. Wållberg-Jonsson S, Dahlén GH, Nilsson TK, Rånby M, Rantapää-Dahlqvist S. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand Factor in rheumatoid arthritis. Clin Rheumatol 1993;12:318-24.
48. Lefvert AK, Hamsten A, Holm C. Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before age 45 years. Arterioscler Thromb Vase Biol 1995;15:665-8.
49. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intracellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
50. Fitzgerald OM, Barnes L, Woods R, McHugh L, Barry C. O'Loughlin S. Direct immunofluorescence of normal skin in rheumatoid arthritis. Br J Rheumatol 1985;24:340-5.
51. Huhtasaari F, Asplund K, Stegmayr B, Lundberg V, Wester PO. Trends in cardiovascular risk factors in the Northern Sweden MONICA study: Who are the winners? Cardiovasc Risk Factors 1993;3:215-21.
52. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia 1995;38:1061-8.
53. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J 1981;319-28.
54. Heliövaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking as a risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.
55. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996;39:732-5.
56. Huhtasaari F, Asplund K, Wester PO. Cardiovascular risk factors in the Northern Sweden MONICA study. Acta Med Scand 1988;224:99-108.
57. Aho K, Salonen JT, Puska P. Autoantibodies predicting death due to cardiovascular disease. Cardiology 1982;69:125-9.
58. Heliövaara M, Aho K, Knekt P, Aromaa A, Maatela J. Reunanen A. Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis 1995;54:811-4.
59. Pincus T, Callahan LF. The "side effects" of rheumatoid arthritis: joint destruction, disability and early mortality. Br J Rheumatol 1993;32 Suppl 1:28-37.
60. Book C, Jacobsson LTH, Saxne T, Sjöblom KG. Rheumatoid arthritis and mortality: assessment of risk factors and mortality risk [abstract]. Arthritis Rheum 1996;39 Suppl:S142.
61. Myllykangas-Luosujärvi R, Aho K, Isomäki H. Death attributed to anti-rheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol 1995;22:2214-7.
62. Leigh JP, Fries JF. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol 1991;18:1307-12.
63. Gough A, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;334:23-7.
64. Kirwan JR. The effect of gluococorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
65. Lehtinen K, Isomäki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J Rheumatol 1991;18:524-9.
66. Savolainen A, Isomäki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201-3.
67. Foster S, Forstot L, Wilson L. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology 1984;91:1253-63.
68. Bjelle A, Cedergren B, Rantapää Dahlqvist S. HLA B27 in the population of Northern Sweden. Scand J Rheumatol 1982;11:23-6.
69. Rantapää-Dahlqvist S. Nordmark L. Bjelle A. HLA-B27 and involvement of sacroiliac joints in rheumatoid arthritis. J Rheumatol 1984;1:27-32.
70. Uddhammar A, Nilsson Sojka B, Rantapää-Dahlqvist S. HLA antigens in polymyalgia rheumatica in Northern Sweden. Clin Rheumatol 1996;15:486-90.
71. Saikku P, Leinonen M, Manila K, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;1:983-6.
72. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;16:273-8.
73. Weyand CM, Hicock KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity. Ann Intern Med 1992;117:801-6.
74. Eberhardt K, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1966;55:34-9.
75. Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study. J Rheumatol 1995;22:2027-33.